Medical Drugs Delivery Applications
-
Microscope System for Drug discovery and development
In this example, the aggregation of magnetic nanoparticles labeled with DiR is monitored in real time. Tumor microvasculature is labeled using ...
By Mauna Kea Technologies based in Paris, FRANCE.
-
Environmental solutions for the load transfer platforms (LTP)
The GEOWEB system’s ability to effectively spread loads allows it to bridge and distribute loads to fewer pile cap columns, increasing the spacing between columns compared to traditional concrete pile cap systems. This reduction in pile cap columns significantly decreases costs on a project. When compared to geogrid solutions for minimizing columns, the GEOWEB® LTP system can be constructed with less expensive sand infill instead of aggregate/gravel. Deployment operations do not require low pressure ...
By Presto Geosystems based in Appleton, WISCONSIN (USA).
-
Maldi MSI in Drug Development
Researchers have found many uses for MALDI mass spectrometry imaging in the process of drug ...
By HTX Technologies, LLC based in Chapel Hill,, NORTH CAROLINA (USA).
-
Highly customized aptamer discovery solutions for hot areas for aptamers sector
Aptamers are short strands of DNA or RNA with unique secondary and tertiary structures that enable highly selective binding to various types of targets. While aptamers are similar to antibodies in their ability to specifically bind with high affinity, there are some key differences between antibodies and aptamers which have prompted an increase in aptamer development projects. Several hot areas for aptamers, along with specific aptamer advantages, are outlined below. ...
By Base Pair Biotechnologies, Inc. based in Pearland, TEXAS (USA).
-
Specialty Microporous Membrane for Specialty Industry
Because of their unique characteristics and reliable performance, Celgard® microporous membrane application can also be used in a broad range of specialty energy storage and other barrier-type applications, including NiZn batteries, zinc-air hearing aid batteries, NiCd aircraft batteries, ultra-capacitors, transdermal drug delivery, implantable and other medical devices. In addition to our standard product offering, Celgard offers a variety of specialty membranes that can be laminated to a PP nonwoven material ...
By Celgard LLC based in Charlotte, NORTH CAROLINA (USA).
-
Groundbreaking Proprietary Investigational Drug for Crohn`s disease
Effecting an estimated one million Americans, Crohn's disease can be highly debilitating and remains a serious burden for both patients and healthcare systems. ...
By RedHill Biopharma Ltd. based in Tel-Aviv, ISRAEL.
-
Solutions for Nephrology
When Otsuka saw a need for clinical expertise and research in the nephrology space, we decided to lead the way. For more than 20 years, we have been bringing our research and expertise to this therapeutic area. We have focused on developing novel drugs in areas of unmet need, such as autosomal dominant polycystic kidney disease and hyponatremia, that have changed the treatment landscape. Our long-term perseverance has led to major breakthroughs, giving patients renewed hope and clinicians more options than ...
By Otsuka America Pharmaceutical, Inc based in Princeton, NEW JERSEY (USA).
-
Retinal vessel analysis system for Cardiology industry
Retinal vessel analysis provides biomarkers on the condition and function of vessels as well as their regulation within microcirculation. It therefore complements the diagnostics of macrocirculation to include the non-invasive vascular diagnostics of ...
By iMEDOS Health GmbH based in Jena, GERMANY.
-
Bioactive molecule solutions for life sciences industry
Human and Animal Health: At Leaf we use our SupraVec® technology to enable our partners in the development of therapeutic drugs, diagnostics and vaccines. SupraVec enables us to lower costs making drugs more affordable and more widely available to a global population. The rapid production speed of SupraVec can deliver products to market much faster, subsequently reducing the time it takes to get new drugs to patients more ...
By Leaf Expression Systems based in Colney, UNITED KINGDOM.
-
Pharmaceutical Preparation and Drug Delivery Devices for Pharmaceutical Companies
Yukon’s Vialok products are behind tens of millions of safe, needle-free medication preparations around the world. We’re trusted by top medical device and pharmaceutical companies, healthcare workers, and even patients who use our vial adapters safely at ...
By Yukon Medical, LLC based in Durham,, NORTH CAROLINA (USA).
-
Drug development & personalize care solutions for pharma & biotech industry
Realize the value of global clinical and genomic data with us. We help reduce your risk, enhance your pipeline value and advance your enterprise data strategy by solving the barriers of data access and enabling rapid insight ...
By BC Platforms based in Zürich, SWITZERLAND.
-
Sample analysis for the drug development sector
DART enables near effortless inspection of tablets, powder, and liquid formulations. Qualitative and quantitative analysis are completed by using commercially available LC/MS systems from all of the major mass spectrometry vendors. Rapid reaction monitoring is facilitated with the development of our Mobile DART-Acquity QDa platform which can move from laboratory to pilot plant in minutes enabling generation of high quality information in seconds to improve your decision making process. ...
By Bruker Corporation based in Billerica, MASSACHUSETTS (USA).
-
Single-cell omics with Live-seq
Introducing single-cell biopsy The novel non-invasive method for single-cell omics The novel method that keeps your cells alive during biopsy from single cells Single-cell omics addresses cellular heterogeneity head on by isolating and analyzing molecular components from individual cells. While many of the existing technologies rely on cell lysis — single-cell biopsy is the only non-invasive single-cell analysis method that allows researchers to take transcriptome snapshots of a ...
By Cytosurge AG based in Glattbrugg, SWITZERLAND.
-
Antibody Discovery
The antibody drug discovery process differs from the traditional drug discovery of small molecules as it requires the development of hybridomas and the engineering of antibodies to recognize a specific target protein. The production of recombinant antibodies in cancer treatment as well as the development of neutralizing antibodies for infectious diseases, has allowed antibody discovery platforms to interrogate the immune repertoire and develop novel antibody libraries using flow cytometry analysis and cell ...
By NanoCellect Biomedical, Inc. based in San Diego, CALIFORNIA (USA).
-
Microscopy Technology for Pathogens Hub
Infectious diseases are caused by pathogenic microorganisms such as bacteria, viruses, fungi or prions. Thanks to scientific advances in microbiology, host-pathogen interactions, and drug development, many of these infections can now be controlled or cured. Despite great efforts and the development of advanced technologies to investigate infectious agents, there are still many open questions regarding pathogen life cycles, how they cause disease and how can they be ...
By ONI based in Oxford, UNITED KINGDOM.
-
Data Annotation for Life Sciences
From accelerating drug discovery to leveraging real world evidence, Centaur Labs provides life sciences innovators with high-quality medical data annotations at unprecedented speed and ...
By Centaur Labs based in Boston, MASSACHUSETTS (USA).
-
Respiratory Solutions for Patients Mechanically Ventilated
Aerogen is the only closed-circuit aerosol drug delivery system that mitigates the transmission of patient-generated infectious ...
By Aerogen based in Dangan, IRELAND.
-
Bioprinter for Human Skin Printing
Facilitate the construction of human skin equivalents for wound healing research, cosmetic product development or drug delivery ...
By Regenhu based in Villaz-St-Pierre, SWITZERLAND.
-
Proteome array screening solutions for protein small molecule interactions sector
Explore interaction profiles and identify off-target binding. Most drugs in common use are small organic molecules which interact functionally with proteins, either acting as ligands for receptors, inhibiting enzymes or blocking protein interactions, etc. Their activities have generally been established by specific cellular and molecular assays to determine mode of action. While frequently well tolerated, side-effects are nevertheless commonplace and can be the result of unexpected interference with unintended ...
By Cambridge Protein Arrays Ltd. (CPAP) based in Cambridge, UNITED KINGDOM.
-
The Chrysalis Solution to Mitigate Radiation Therapy-Induced Tissue Damage
Prescriptive Use To Mitigate Radiotherapy Damage To Normal Tissue and Allow More Effective Cancer Therapy. Almost 70% of all patients with cancer receive radiotherapy alone or in combination with surgery or chemotherapy. The amount of radiation that can be used to control tumor growth, however, is limited by normal tissue damage. Development of drugs to selectively reduce radiotherapy-induced normal tissue damage may improve post-therapy quality of life and allow more aggressive radiotherapy protocols to better ...
By Chrysalis BioTherapeutics, Inc. based in Galveston, TEXAS (USA).
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you